Grade Prostatic Intraepithelial Neoplasia (HGPIN) is the putative precursor lesion to prostatic adenocarcinoma (PCa), but the precise relationship between HGPIN and PCa remains unclear.
INTRODUCTION
Prostate cancer (PCa) is the most common malignancy of visceral organs in men, and it is estimated that PCa will kill 26,120 men in the United States in 2016 (1) . High Grade Prostatic Intraepithelial Neoplasia (HGPIN) is a putative precursor lesion to PCa (2) (3) (4) . Earlier studies have demonstrated that HGPIN shares some molecular features of PCa. Similar to the invasive PCa, HGPIN can show 8p12-21 allelic loss (5) and gain of chromosomes 7, 8, 10, and 12 (6) (7) . TMPRSS2:ERG fusions, which occur in about half of PCa, were detected in 10-20% of HGPIN (8) (9) (10) . HGPIN may also show increased protein expression of c-MYC (11) , c-ERBB-2 (HER-2) (12), c-MET (13) , BCL-2 (14) , and alphamethylacyl-CoA racemase (15) , as well as mutant p53 (16) . Different from invasive PCa, HGPIN generally does not harbor PTEN deletion (17) (18) or RB loss (16) , although conflicting data have been published (19) (20) . Based on these data, it is not yet clear whether HGPIN is an immediate precursor of PCa, and genetic alterations that may drive HGPIN to invasive PCa remain to be established.
The precise relationship between Gleason pattern 3 (Gp3) and Gleason pattern 4 (Gp4) tumors, and whether Gp3 progresses to Gp4, has similarly been uncertain. Studies from our laboratory and others have used TMPRSS2:ERG fusion breakpoint sequencing to demonstrate a clonal relationship between adjacent Gp3 and Gp4 tumor foci in Gleason score 7 (GS7) PCa (21, 22) . Since then, by whole exome sequencing, we have confirmed that these clonal Gp3 and Gp4 tumor foci share multiple mutations (truncal mutations), but that many additional mutations may be unique to the clonally related Gp3 and Gp4 tumors (Sowalsky et al., submitted for publication). In this study, we have isolated multiple HGPIN lesions associated with a GS7 tumor, in conjunction with adjacent Gp3 and Gp4 foci, in order to determine the relationship between these entities. Our results establish that the HGPIN lesions, Gp3, and Gp4 foci all share a common origin, but multiple mutations common to the Gp3 and Gp4 foci were not detected in the HGPIN lesions. These findings argue against a straightforward stepwise progression from HGPIN to PCa, and indicate that HGPIN may be genetically stable entities and represent distant precursors to PCa.
MATERIALS AND METHODS

Tissue Selection
Tissue from radical prostatectomy (RP) specimens was collected and deidentified in accordance with Beth Israel Deaconess Medical Center IRB protocol #2010-P-000254. Invasive tumors were graded using the modified Gleason grading system established by the 2014 International Society of Urological Pathology (ISUP) consensus conference (23, 24) . RP cases of GS7 PCa were reviewed for tumor-associated HGPIN lesions. A single case harboring multiple foci of HGPIN was selected. The patient was a 66-year-old white male with PCa of ISUP Grade Group 2 (Gleason score 3+4=7) staged pT2cN0 (patient 2 in our previous study (21) ). The entire prostate was submitted for histological examination. Prostatic tissue was fixed in formalin, processed, and embedded in paraffin using standard methods. A total of six ERG-positive tumor-associated HGPIN foci (concordant with the ERG-positive PCa) were identified. Genetic alterations in the adjacent Gp3 and Gp4 tumors had been previously mapped using whole exome sequencing (Sowalsky et al., submitted for publication). Gp3, Gp4 and HGPIN lesions were identified by a urological pathologist (HY). HGPIN lesions were diagnosed based on architecturally benign glands lined by cytologically malignant luminal cells with visible nucleoli at 200× and presence of basal cells at the periphery, after excluding intraductal carcinoma (25) . Tumor-associated HGPIN was defined as HGPIN located either within the index tumor or on the edge of the index tumor. Sixmicron sections were stained with H&E, anti-ERG (clone EPR3863, Epitomics, Burlingame, CA), and PIN-4 antibodies (Biocare Medical, Concord, CA) according to manufacturer's suggested protocols.
Laser-Capture Microdissection
Six-micron serial sections from this case were cut onto polyethylene naphthalate metal frame slides (Applied Biosystems, Foster City, CA) and lightly stained with the Arcturus Paradise Plus Staining Kit (Applied Biosystems, Foster City, CA). Using consecutive ERG and PIN-4 immunostains as references, epithelial cells were collected using laser-capture microdissection from a total of 9 samples, including 6 tumor-associated HGPIN foci (A to F), 1 normal, 1 Gp3, and 1 Gp4 tumor focus. Epithelial cells from the 9 samples were captured onto separate caps, using 20-micron infrared pulses and excised from the adjacent tissue using the ultraviolet laser on an ArcturusXT Nikon Eclipse Ti-E microdissection system. Each captured region was checked against the reference slides for accuracy prior to DNA extraction.
Library Preparation and Deep Sequencing
Genomic DNA (gDNA) was extracted and isolated using the QIAamp DNA FFPE Tissue Kit (Qiagen, Valencia, CA). Multiplex PCR was performed to amplify 46 tumor mutationspecific targets from no more than 10ng of gDNA per sample. After this initial PCR amplification, the products were purified and used as templates for multiple secondary amplifications using single primer pairs. This resulted in successful amplification of 32 targets in one or more of the HGPIN lesions, including 7 grade-specific (found in only the Gp3 or Gp4 focus) and 25 Gp3 and Gp4-shared mutations identified in the adjacent invasive tumor. For each HGPIN, normal, and tumor control samples, a DNA library was prepared by pooling 5 ng of each PCR product per target. The libraries were then fragmented and prepared for NGS using NEBNext Library Prep for Illumina (New England BioLabs, Ipswich, MA), clustered, and sequenced on a MiSeq (Illumina, San Diego, CA) with 100 cycles paired end (100×100) and 7 additional indexing cycles.
Original sequence data has been deposited in the NCBI Sequence Read Archive under Accession ID SRP074297.
Data Alignment and Determination of Mutations
The sequencing data files were generated from the image data, demultiplexed on CASAVA 1.8.2, and subsequently downloaded in FASTQ format. FASTQ files were aligned to human genome (Hg19) using the Burrows-Wheeler Aligner, and mutations were identified using Varscan 2 for somatic analysis, comparing each cancer or HGPIN BAM file to the normal sequence data, and applying Fisher's exact test to determine whether a mutation was genuine or background. We then applied a filter that limited the sequencing data to only the regions amplified by multiplex PCR, and performed a functional prediction with SNPEff (26) to give the amino acid changes for any known protein-coding regions.
Statistical Analysis
Assuming the minimal purity of HGPIN that was microdissected was 10%, and assuming normal ploidy, our technical lower limit to call a mutation was limited to read depth of at least 20 reads with one read called as mutant. However, with a false-positive probability (α) of 0.05 and a false negative probability (β) of 0.05, our ability to call definitely the genotype at any site was limited to those sites with read depth greater than or equal to 33 reads. This power analysis was performed using G*Power version 3 for Mac.
Quantitative PCR (qPCR)
SYBR Green-based qPCR for a relative quantification (ΔΔC T method) was performed on the positive Gp3 and Gp4 controls, negative controls, normal tissue, and HGPIN lesions. The template amounts for the Gp3, Gp4, and normal were 10 ng each. The template amount for the HGPIN lesions was <10 ng (too low to be accurately quantified). Each sample was performed in triplicate using patient-specific TMPRSS2:ERG fusion primers, with an ERG primer set for the internal reference ERG gene that was not associated with the TMPRSS2:ERG fusion. Additionally, three (10, 1, and 0.1 ng) template amounts of the Gp3 positive control DNA were used for the linearity analysis. 5 μL of 2× QuantiFast SYBR Green PCR master mix (Qiagen, Valencia, CA) was mixed with the forward and reverse primers each at a final concentration of 1 μM and the respective DNA amounts to bring each sample to a final volume of 10 μL. Cycling conditions specified by the manufacturer were used, for a total of 45 cycles using a StepOnePlus Real-Time PCR instrument (Life Technologies, Foster City, CA). Melting curve analysis was used to confirm primer pair specificity in that each well contained only a single amplified product.
RESULTS
Identification and Isolation of Tumor-associated HGPIN Lesions
TMPRSS2:ERG rearrangement is known to be an early genetic event in PCa development.
Therefore, HGPIN lesions that showed concordant ERG staining patterns with the adjacent tumors were considered as potential precursors for invasive tumors. We reviewed H&E stains, PIN-4 and ERG immunostains of the selected RP case. A total of six spatially separated tumor-associated ERG-positive HGPIN lesions, HGPIN foci A to F, were identified. Figure 1 illustrates the relationship of HGPIN lesions with the invasive tumor. Figure 2 shows the concordant ERG immunoreactivity in the HGPIN foci A, C, and F, Gp3, and Gp4 tumors, indicating that they potentially share the clonal lineage. Figure 3 shows HGPIN-C and HGPIN-F at a higher magnification. Pictures of the remaining four foci (HGPIN-A, -B , -D, -E) at high magnifications are shown in Supplementary Figures 1 and 2 . Epithelial cells of all the six HGPIN lesions were captured individually using laser-capture microdissection (LCM). The insert in Figure 3F shows the captured HGPIN-F on the LCM polymer cap, demonstrating a clean harvest with minimal contamination by surrounding tissue. Next, we asked if the six ERG-positive HGPIN lesions shared the same TMPRSS2:ERG breakpoints with the adjacent invasive tumor. Using patient-specific primers for the TMPRSS2:ERG breakpoints (21), we generated PCR products of ~150 bp from gDNA of all six foci of HGPIN, but not in the no-template negative control DNA ( Figure 4A) . The presence of a ~150 bp PCR product in each lane suggested that all six HGPIN lesions shared the same TMPRSS2:ERG fusion as the invasive tumor. Sanger sequencing of PCR products demonstrated that the breakpoints in all six foci were the same as the breakpoints of invasive tumor ( Figure 4B ). The breakpoint coordinate for ERG was chr21:39870028 and the TMPRSS2 coordinate was chr21:42871313.
To rule out the possibility that detection of the fusion breakpoint in the HGPIN lesions was due to trace contamination from the adjacent tumor cells during LCM, we asked if the TMPRSS2:ERG fusion gene detected in the HGPIN lesions was present at comparable levels to the adjacent Gp3 and Gp4 invasive tumors. For this purpose, quantitative PCR (qPCR) was performed on the DNA extracted from Gp3, Gp4, normal tissue, and HGPIN samples. For this analysis, we set purity of our Gp3 sample to 1 because the microscopic anatomy of Gp3 is similar to that of HGPIN, i.e. well-defined glands surrounded by fibromuscular stroma. As shown in Figure 5A , relative quantity (RQ) values of Gp4, normal tissue, and HGPIN-F were 1.573, 0.030, and 0.492, respectively. The latter approximately 50% purity of fusion-positive cells in the HGPIN samples relative to the Gp3 sample was consistent with basal cells and residual normal luminal epithelial cells in the microdissected HGPIN, and confirms that the DNA containing the fusion breakpoint was not derived from trace contaminating tumor cells. The cribriform Gp4 samples had a higher purity compared to Gp3 samples, which is consistent with less stroma in the microdissected cribriform Gp4. Therefore, the results of purity analysis of HGPIN, Gp3, and Gp4 samples can be explained by their respective histological features. Taken together, these findings establish that the HGPIN foci were clonally related to the invasive tumor, as they all shared the same TMPRSS2:ERG breakpoints as the invasive Gp3 and Gp4.
OR2AP1 Truncal Mutation Detected in One HGPIN Lesion
We had previously carried out whole exome sequencing on the LCM purified adjacent Gp3 and Gp4 foci from this patient, as well as adjacent nonmalignant prostate, to identify a series of mutations that were common to both the Gp3 and Gp4 tumors (presumably truncal mutations), as well as mutations that were unique to the Gp3 or Gp4 foci (Sowalsky et al., submitted for publication). Therefore, we next tested whether the HGPIN lesions harbored any of the somatic mutations detected in the Gp3 and Gp4 tumors. We used PCR and amplicon resequencing to assess for the presence of 25 mutations that were shared by Gp3 and Gp4 tumors (truncal mutations), 3 mutations found only in the Gp3 focus, and 4 mutations found only in the Gp4 focus (primer sequences listed in Supplementary Table 1 ). As shown in Table 1 , all six foci of HGPIN successfully generated mutational landscape data, with most of the 32 amplicons generating sufficient read depth to call a mutation with a false positive probability (α) = 0.05 and call a wild-type allele with a false negative probability (β) = 0.05. 
Author Manuscript
Author Manuscript
Surprisingly, there were no mutations detected in the DNA from HGPIN lesions A, B, C, D, or E. In HGPIN-F, we detected only one mutation, which was in OR2AP1 (a truncal mutation found in both the Gp3 and 4 foci that resulted in an amino acid change from leucine to phenylalanine at codon 283). The OR2AP1 gene in HGPIN-F had a total coverage of 159 reads, with 44 reads (28%) for the missense thymine mutation (g.chr12:55969047G>T) (21 positive strand and 23 negative strand) and 113 reads (71%) for the normal coding guanine allele (54+, 59−) ( Figure 5B ; Table 1 ). Assuming normal ploidy and a heterozygous mutation, this 28% frequency is in excellent agreement with the estimated 50% purity of the HGPIN sample, and suggests that it is present in virtually all of the HGPIN-F cells.
DISCUSSION
The results of this case study show that the HGPIN lesions and adjacent Gp3 and Gp4 tumor foci in this patient had identical TMPRSS2:ERG breakpoints. Importantly, using qPCR for relative quantification of the TMPRSS2:ERG breakpoints, we confirmed that their detection in the HGPIN lesions was not caused by tissue contamination during LCM. Moreover, the absence of truncal mutations (found in the Gp3 and Gp4 tumors) in the HGPIN lesions excluded the possibility of a retrograde acinar colonization that may morphologically mimic HGPIN (27) . Together these results establish that the HGPIN, Gp3 and Gp4 foci in this patient were clonally related, and support previous studies indicating that HGPIN is a precursor to PCa.
To further address the relationship between these clonal HGPIN lesions and adjacent Gp3 and Gp4 tumor foci, we assessed the HGPIN for somatic mutations found in the Gp3 and Gp4 tumor foci. We discovered that one of six HGPINs harbored a mutation in OR2AP1, a somatic mutation that was shared by the invasive Gp3 and Gp4 (but not present in nonmalignant prostate from this patient). OR2AP1 codes for olfactory receptor family 2 subfamily AP member 1, a prostate-specific G-coupled receptor. Another member of the olfactory receptor family, prostate specific G protein-coupled receptor (PSGR), has been reported to be involved in development and progression of PCa (28) (29) . However, the functional role of this OR2AP1 mutation in PCa development is unclear. Therefore, although it may be involved in the progression of HGPIN to PCa, it may instead have emerged as a passenger mutation at some point after the TMPRSS2:ERG fusion.
Significantly, with the exception of this OR2AP1 mutation in one HGPIN focus, we did not detect any of the other 32 mutations that we had observed in the adjacent invasive tumor. Of these, 25 were shared between the associated Gp3 and Gp4 tumors, so many or most are likely to reflect truncal mutations in the invasive tumor. Therefore, although the single OR2AP1 mutation is consistent with a stepwise progression from HGPIN to invasive cancer, one would then expect to detect further intermediates containing additional truncal mutations. While it is possible that these were present but missed, we instead suggest that these HGPIN lesions persisted as a relatively genetically stable entity that was only distantly related to the adjacent Gp3 and Gp4 tumor foci. The lack of intermediates with additional truncal mutations may then reflect microheterogenetiy within the HGPIN, with PCa in this case arising from a single HGPIN cell from a minor HGPIN subclone that already contained 
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Author Manuscript multiple mutations. Alternatively, it is possible that a genomic alteration occurring in a HGPIN subclone with the OR2AP1 mutation caused genomic instability and rapid accumulation of mutations leading to invasive cancer. Interestingly, we did detect an MSH6 mutation in the Gp3 tumor from this case, which is often associated with further genomic instability. However, it was not found in the Gp4 focus, so is presumably not truncal (see Table 1 ).
Given the technical challenge of laser capture microdissection and subsequent molecular analysis of very small amounts of DNA from multiple HGPIN foci from the formalin-fixed paraffin-embedded tissue, our study has some limitations. In particular, the amount of gDNA recovered from each focus was variable, which may have contributed to different amplification efficiencies for each target. Consequently, not all targets generated sequencing results with comparable coverage in all samples. For example, HGPIN foci A, B, D, and E generated minimal or no reads for OR2AP1, therefore, we lack the statistical power for this amplicon to determine conclusively that we did not miss the OR2AP1 mutation in these HGPIN lesions, and thus we cannot rule out the possibility that the OR2AP1 mutation emerged in multiple HGPIN foci prior to the emergence of cancer. In addition, very low input DNA sequenced may be associated with unequal coverage, amplification artifacts, and contamination issues. Nonetheless, more targets were successfully sequenced than unsequenced in all samples, with a majority of targets having unbiased sequence coverage of greater than 50×, supporting our conclusions of a mutation-poor landscape in HGPIN lesions in this case.
Significantly, while our study was carried out in a single TMPRSS2:ERG fusion positive case, a very recent study examined genetic profiles of HGPIN and PCa in 6 fusion-negative Asian patients (30) . Consistent with our current study, the HGPIN and PCa were found to be clonal based on shared genetic alterations in 4 cases. Moreover, significantly fewer mutations were found in the HGPIN versus PCa, indicating substantial genetic evolution from HGPIN to PCa with is consistent with our findings. Overall, while the data clearly establish a clonal relationship between HGPIN and PCa, they further indicate that HGPIN are relatively genetically stable and support clinical observations and the conservative management of men with HGPIN. However, given the limited applicability from this single case study, further studies are needed to elucidate mechanisms that may drive HGPIN to PCa, and to determine whether there are molecular features of some HGPIN that are associated with increased risk of progression. Table 1 Sequencing Coverage of 32 Targets
Gene Target Mutation PIN-A Reads PIN-B Reads PIN-C Reads PIN-D Reads PIN-E Reads PIN-F Reads Normal Reads Gp3 Reads Gp4 Reads Shared:
ACOXL
